1OHR

VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE

Structural Biology Knowledgebase: 1OHR SBKB.org


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.1 Å
  • R-Value Observed: 0.200

wwPDB Validation Full Report


Literature

Macromolecules
Sequence Display for 1OHR

Classification: ASPARTYL PROTEASE

Total Structure Weight: 22175.38

Macromolecule Entities
Molecule Chains Length Organism Details
ASPARTYLPROTEASE A, B 99 Human immunodeficiency virus 1 Mutation: V3I
Details: COMPLEXED WITH VIRACEPT

Small Molecules
Ligands 1 Unique
ID Chains Name / Formula / InChI Key 2D Diagram 3D Interactions
1UN
Query on 1UN

A 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL-BENZOYLAMINO)- 4-PHENYL SULFANYL-BUTYL]-DECAHYDRO-ISOQUINOLINE- 3-CARBOXYLIC ACID TERT-BUTYLAMIDE
NELFINAVIR MESYLATE AG1343 (Synonym)
C32 H45 N3 O4 S
QAGYKUNXZHXKMR-HKWSIXNMSA-N
Ligand Explorer
 
JSmol
External Ligand Annotations
ID Binding Affinity (Sequence Identity %)
1UN Ki: 0.53 - 2 nM (88 - 98) BindingDB

Ki: 2 nM  BindingMOAD
Ki: 2 nM  PDBbind

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.1 Å
  • R-Value Observed: 0.200
  • Space Group: P 21 21 21

Unit Cell:

Length (Å) Angle (°)
a = 52.04 α = 90.00
b = 59.38 β = 90.00
c = 61.67 γ = 90.00

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History

Deposition Data

  • Deposited Date: 1997-09-27
  • Released Date: 1998-12-09
  • Deposition author(s): Davies II, J.F.

Revision History

  • 2011-07-13
    Type: Version format compliance | Details: compliance with PDB Exchange Dictionary V4